Profitability Ratios
| Ratio |
Value |
| GP Margin |
15.5% |
| EBIT Margin |
-0.1% |
| EBITDA Margin |
5.7% |
| Operating Margin |
-0.1% |
| Pretax Margin |
-4.8% |
| Cont. Ops Margin |
-6.6% |
| Net Margin |
-6.6% |
| Bottom Line Margin |
-6.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.78 |
| Quick Ratio |
0.85 |
| Solvency Ratio |
-0.006 |
| Cash Ratio |
0.40 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.01 |
| Forward PEG |
0.01 |
| Price/Book |
7.09 |
| Price/Sales |
0.31 |
| Price/FCF |
34.76 |
| Price/Op Cash Flow |
6.71 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.6211 |
| Debt/Equity |
18.3400 |
| Debt/Capital |
0.9483 |
| Long-Term Debt/Capital |
0.9446 |
| Financial Leverage |
29.53 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
4.58 |
| Operating Cash Flow Ratio |
0.157 |
| Operating Cash Flow/Sales |
4.5% |
| Free Cash Flow/Operating Cash Flow |
19.3% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.60 |
| Interest Coverage |
-0.0186 |
| Short-Term Operating Cash Flow Coverage |
2.54 |
| Operating Cash Flow Coverage |
0.06 |
| Capital Expenditure Coverage |
1.24 |
| Dividend + Capital Expenditure Coverage |
0.91 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
-20.2073% |
| Dividend Yield |
4.4002% |
| Dividend Yield % |
4.4002% |
| Dividend Per Share |
0.5188 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
38.63 |
| EPS |
-2.567 |
| Debt/Share |
32.2844 |
| Cash/Share |
4.47 |
| Book Value/Share |
1.67 |
| Tangible BV/Share |
1.35 |
| Equity/Share |
1.66 |
| Operating Cash Flow/Share |
1.756 |
| Capital Expenditure/Share |
1.417 |
| FCF/Share |
0.339 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.394 |
| Earnings Before Tax/EBIT |
55.400 |
| Price/Fair Value |
7.09 |
| Debt/Market Cap |
2.4630 |
| Effective Tax Rate |
-39.4% |
| Enterprise Value Multiple |
17.13 |
CC - The Chemours Company